Home
About
Overview
Sharing Data
ORCID
Help
History (13)
ER stress modulates cellular metabolism.
Treatment advances in Alzheimer's disease based on the oxidative stress model.
Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN.
Hemodynamic and biologic determinates of arteriovenous fistula outcomes in renal failure patients.
Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium.
Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium. J Clin Oncol. 2010 Nov 01; 28(31):4740-6.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Bone Marrow
Chicago
Disease-Free Survival
Female
Humans
Intracellular Signaling Peptides and Proteins
Kaplan-Meier Estimate
Leukemia, Lymphocytic, Chronic, B-Cell
Lymphoma, Follicular
Lymphoma, Large B-Cell, Diffuse
Lymphoma, Mantle-Cell
Lymphoma, Non-Hodgkin
Male
Middle Aged
Mucositis
Pneumonia
Protein Kinase Inhibitors
Remission Induction
Sirolimus
TOR Serine-Threonine Kinases
Treatment Outcome
authors with profiles
Koen Van Besien
Everett Vokes
Sonali Smith
Theodore Karrison